title: Treatment options of AIDS-related lymphoma.
abstract: Recently, the median survival of patients with AIDS-related lymphoma has changed significantly. This effect is mainly because of changes in the use of antiviral (highly active antiretroviral therapy; HAART) or chemotherapy regimens. Several novel treatment options have been explored in patients with lymphoma. It is hoped that innovative strategies will lead to a survival benefit in these patients. In this review, we present an update of current strategies for the treatment of AIDS-related lymphoma.
authors.affiliation: Medizinische Universitätsklinik und Poliklinik I, Sigmund-Freud-Str 25, 53105 Bonn, Germany. picasso@uni-bonn.de
authors.forename: Ingo G H
authors.initials: IG
authors.lastname: Schmidt-Wolf
authors.forename: Jürgen K
authors.initials: JK
authors.lastname: Rockstroh
authors.forename: Uwe
authors.initials: U
authors.lastname: Schlegel
authors.forename: Hendrik
authors.initials: H
authors.lastname: Pels
authors.forename: Ulrich
authors.initials: U
authors.lastname: Mey
authors.forename: John
authors.initials: J
authors.lastname: Strehl
authors.forename: Rudolf
authors.initials: R
authors.lastname: Weiss
authors.forename: Dieter
authors.initials: D
authors.lastname: Huhn
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D023241:Antiretroviral Therapy, Highly Active; D015658:HIV Infections / Q000188:drug therapy; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D007167:Immunotherapy; D016483:Lymphoma, AIDS-Related / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D033581:Stem Cell Transplantation
chemical_list: D000970:Antineoplastic Agents; D006918:Hydroxyurea